Search for other papers by Monika Karczewska-Kupczewska in
Google Scholar
PubMed
Search for other papers by Agnieszka Nikołajuk in
Google Scholar
PubMed
Search for other papers by Radosław Majewski in
Google Scholar
PubMed
Search for other papers by Remigiusz Filarski in
Google Scholar
PubMed
Search for other papers by Magdalena Stefanowicz in
Google Scholar
PubMed
Search for other papers by Natalia Matulewicz in
Google Scholar
PubMed
Search for other papers by Marek Strączkowski in
Google Scholar
PubMed
Introduction Obesity predisposes to the development of type 2 diabetes, dyslipidemia, hypertension, atherosclerosis, several types of cancer and other disorders. Insulin resistance is a major pathophysiological link between obesity and its
Search for other papers by Wenjun Long in
Google Scholar
PubMed
Search for other papers by Tuo Zhou in
Google Scholar
PubMed
Search for other papers by Xiuping Xuan in
Google Scholar
PubMed
Search for other papers by Qiuli Cao in
Google Scholar
PubMed
Search for other papers by Zuojie Luo in
Google Scholar
PubMed
Search for other papers by Yingfen Qin in
Google Scholar
PubMed
Search for other papers by Qin Ning in
Google Scholar
PubMed
Search for other papers by Xiaoping Luo in
Google Scholar
PubMed
Search for other papers by Xuemei Xie in
Google Scholar
PubMed
growth (CG-IUGR) is much higher than that in normal people ( 10 , 11 ). Insulin resistance has been considered as an early manifestation as well as a crucial mechanism for metabolic disturbance in later life of individuals with CG-IUGR ( 12 , 13 , 14
Search for other papers by Silan Zheng in
Google Scholar
PubMed
Search for other papers by Meifeng Tong in
Google Scholar
PubMed
Search for other papers by Lianqin Dong in
Google Scholar
PubMed
Search for other papers by Chunmin Du in
Google Scholar
PubMed
Search for other papers by Xin Zheng in
Google Scholar
PubMed
Search for other papers by Liying Wang in
Google Scholar
PubMed
Search for other papers by Peiying Huang in
Google Scholar
PubMed
Search for other papers by Wei Liu in
Google Scholar
PubMed
Search for other papers by Mingzhu Lin in
Google Scholar
PubMed
The School of Clinical Medicine, Fujian Medical University, Fuzhou, China
Search for other papers by Changqin Liu in
Google Scholar
PubMed
accurately predict insulin resistance (IR), prediabetes, and type 2 diabetes mellitus (T2DM) ( 15 , 16 , 17 , 18 ). In the present study, we aimed to explore whether the new adiposity indices (LAP, VAI, and TyG) could predict the risk of HS quantified by
Search for other papers by Tatsuya Kondo in
Google Scholar
PubMed
Search for other papers by Nobukazu Miyakawa in
Google Scholar
PubMed
Search for other papers by Sayaka Kitano in
Google Scholar
PubMed
Search for other papers by Takuro Watanabe in
Google Scholar
PubMed
Search for other papers by Rieko Goto in
Google Scholar
PubMed
Search for other papers by Mary Ann Suico in
Google Scholar
PubMed
Search for other papers by Miki Sato in
Google Scholar
PubMed
Search for other papers by Yuki Takaki in
Google Scholar
PubMed
Search for other papers by Masaji Sakaguchi in
Google Scholar
PubMed
Search for other papers by Motoyuki Igata in
Google Scholar
PubMed
Search for other papers by Junji Kawashima in
Google Scholar
PubMed
Search for other papers by Hiroyuki Motoshima in
Google Scholar
PubMed
Search for other papers by Takeshi Matsumura in
Google Scholar
PubMed
Search for other papers by Hirofumi Kai in
Google Scholar
PubMed
Search for other papers by Eiichi Araki in
Google Scholar
PubMed
phenotype in metabolic diseases, such as metabolic syndrome and type 2 diabetes. These metabolic disturbances are closely associated with insulin resistance. Hepatic insulin resistance also causes dyslipidemia, oxidative stress, endoplasmic reticulum (ER
Search for other papers by Hong Wang in
Google Scholar
PubMed
Search for other papers by Jie Cao in
Google Scholar
PubMed
Search for other papers by Jian-bin Su in
Google Scholar
PubMed
Search for other papers by Xue-qin Wang in
Google Scholar
PubMed
Search for other papers by Dong-mei Zhang in
Google Scholar
PubMed
Search for other papers by Xiao-hua Wang in
Google Scholar
PubMed
the formation of glycosylation end products (AGEs) collectively contribute to hypercoagulation in T2D ( 2 ). Insulin resistance, also termed 'reduced insulin sensitivity', is of central importance in the pathogenesis and progression of T2D and
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Service of Endocrinology, Laboratory of Intensive Care, Department of Microbiology and Molecular Medicine, Diabetes, Hypertension and Nutrition
Search for other papers by Geneviève Drifte in
Google Scholar
PubMed
Service of Endocrinology, Laboratory of Intensive Care, Department of Microbiology and Molecular Medicine, Diabetes, Hypertension and Nutrition
Search for other papers by Irène Dunn-Siegrist in
Google Scholar
PubMed
Service of Endocrinology, Laboratory of Intensive Care, Department of Microbiology and Molecular Medicine, Diabetes, Hypertension and Nutrition
Search for other papers by Jérôme Pugin in
Google Scholar
PubMed
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
-activated receptor α (PPARα) and PPARγ respectively (1, 6) . FGF21 has emerged as a key regulator in the metabolism of glucose and lipids (6, 7, 8) . FGF21 may have a potential role as a therapeutic agent for conditions associated with insulin resistance as it has
Search for other papers by Christian Trummer in
Google Scholar
PubMed
Search for other papers by Stefan Pilz in
Google Scholar
PubMed
Search for other papers by Verena Schwetz in
Google Scholar
PubMed
Search for other papers by Barbara Obermayer-Pietsch in
Google Scholar
PubMed
Search for other papers by Elisabeth Lerchbaum in
Google Scholar
PubMed
, evidence is accumulating that vitamin D deficiency is also a risk marker for insulin resistance ( 3 ), cardiovascular disease ( 4 ), infectious and autoimmune diseases ( 1 ), cancer ( 5 ), increased mortality ( 2 ) as well as decreased fertility ( 6
Search for other papers by Lars Peter Sørensen in
Google Scholar
PubMed
Search for other papers by Tina Parkner in
Google Scholar
PubMed
Search for other papers by Esben Søndergaard in
Google Scholar
PubMed
Search for other papers by Bo Martin Bibby in
Google Scholar
PubMed
Search for other papers by Holger Jon Møller in
Google Scholar
PubMed
Search for other papers by Søren Nielsen in
Google Scholar
PubMed
Introduction Obesity is a major risk factor for the development of insulin resistance and type 2 diabetes mellitus (T2DM), but the adverse metabolic consequences of obesity vary between individuals (1) . The mechanisms underlying obesity
Search for other papers by Ling Zhou in
Google Scholar
PubMed
Search for other papers by Ruixue Zhang in
Google Scholar
PubMed
Search for other papers by Shuangyan Yang in
Google Scholar
PubMed
Search for other papers by Yaguang Zhang in
Google Scholar
PubMed
Search for other papers by Dandan Shi in
Google Scholar
PubMed
. 1A , B , C and D ), which was consistent with previous publication showing that non-pregnant C57BL/KsJ-Lep db/+ mice usually did not exhibit diabetic symptoms, such as hyperglycemia and insulin resistance ( 17 ). Nevertheless, AS-IV also had no
Search for other papers by Xiuzhen Hou in
Google Scholar
PubMed
Search for other papers by Junfeng Zhang in
Google Scholar
PubMed
Search for other papers by Hehong Ma in
Google Scholar
PubMed
Search for other papers by Ming Li in
Google Scholar
PubMed
Search for other papers by Pei Wang in
Google Scholar
PubMed
Introduction Gestational diabetes mellitus (GDM) is primarily resulted from insulin resistance and glucose intolerance during pregnancy, affecting 7% of pregnant women globally ( 1 , 2 ). GDM causes higher risks of diabetes, obesity and